A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity(550 views) Sorriento D, Campanile A, Santulli G, Leggiero E, Pastore L, Trimarco B, Iaccarino G
Mol Cancermolecular Cancer (ISSN: 1476-4598), 2009; 8: N/D-N/D.
Keywords: Adenovirus Vector, Antineoplastic Agent, I Kappa B, Immunoglobulin Enhancer Binding Protein, Transactivator Rh Protein, Unclassified Drug, G Protein Coupled Receptor Kinase 5, Grk5 Protein, Human, Lipocortin 5, Recombinant Protein, Transactivator Protein, Animal Experiment, Animal Model, Animal Tissue, Antineoplastic Activity, Apoptosis, Article, Cancer Cell Culture, Cancer Growth, Cancer Inhibition, Cell Survival, Controlled Study, Drug Dose Comparison, Gene Overexpression, Human Cell, In Vitro Study, Mouse, Nonhuman, Transcription Initiation, Transcription Regulation, Viral Gene Delivery System, Bagg Albino Mouse, Cell Proliferation, Chemistry, Drug Effect, Drug Screening, Genetics, Inflammation, Isolation And Purification, Metabolism, Neovascularization (pathology), Protein Tertiary Structure, Staining, Tumor Cell Line, Adenoviridae, Mus Musculus, Annexin A5, G-Protein-Coupled Receptor Kinase 5, Gene Products, Inbred Balb C, Nf-Kappa B, Protein Structure, Staining And Labeling, Xenograft Model Antitumor Assays,
Affiliations: *** IBB - CNR ***
Dipartimento di Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Università Federico II, Napoli, Italy
CEINGE-Biotecnologie Avanzate, Napoli, Italy
Dipartimento di Biochimica e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy
References: Not available.
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(450 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Vitiello M, Finamore E, Falanga A, Raieta K, Cantisani M, Galdiero F, Pedone C, Galdiero M, Galdiero S * Fusion in Coq(596 views) Lecture Notes In Computer Science (ISSN: 0302-9743, 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2001; 2178LNCS: 583-596. Impact Factor:0.415 ViewExport to BibTeXExport to EndNote